| 1.8 |
5.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 1.3 |
3.9 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.3 |
3.8 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 1.0 |
4.1 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.8 |
10.8 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.8 |
3.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.7 |
1.5 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.7 |
3.6 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.7 |
2.1 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.6 |
1.8 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.6 |
1.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.6 |
1.2 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.5 |
2.1 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.5 |
2.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.5 |
1.5 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.5 |
1.5 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.5 |
3.7 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.5 |
2.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
1.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.4 |
1.3 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.4 |
2.6 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.4 |
2.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.4 |
1.3 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.4 |
1.2 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.4 |
2.0 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.4 |
0.4 |
GO:1902724 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.4 |
1.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.4 |
1.5 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.4 |
1.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
2.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.4 |
1.5 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 |
1.7 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.3 |
3.3 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) |
| 0.3 |
1.3 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 |
2.6 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.3 |
1.3 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 |
0.9 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 |
0.6 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.3 |
0.9 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.3 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.3 |
3.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 |
1.2 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 |
1.7 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
0.3 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
0.9 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.3 |
2.0 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.3 |
0.8 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.3 |
1.4 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.3 |
2.1 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.3 |
1.3 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
1.5 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.3 |
3.3 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.3 |
1.0 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.2 |
1.0 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.2 |
2.2 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
1.7 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.2 |
0.7 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.2 |
0.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
3.8 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 |
2.1 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.2 |
0.9 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
2.3 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.2 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.2 |
1.4 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.2 |
0.9 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.2 |
0.9 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.2 |
0.7 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.2 |
0.9 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.2 |
1.5 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
1.5 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
1.5 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
0.6 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.8 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.2 |
1.0 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 |
0.6 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.2 |
0.6 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.2 |
1.4 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.2 |
0.6 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
0.6 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
1.0 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) |
| 0.2 |
2.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
0.6 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.2 |
0.6 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.2 |
0.4 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.2 |
0.6 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.2 |
0.8 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
0.4 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
1.0 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.2 |
0.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.6 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
3.0 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.2 |
0.8 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.2 |
0.8 |
GO:0090467 |
lysine transport(GO:0015819) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.2 |
0.6 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.2 |
0.7 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.2 |
0.9 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.2 |
1.5 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
0.6 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
0.5 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.2 |
1.6 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
0.5 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 |
0.7 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
0.7 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.2 |
2.1 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
0.7 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.2 |
1.8 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
0.7 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
1.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
0.2 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 |
0.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
0.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
0.8 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.2 |
1.4 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.2 |
0.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.2 |
2.8 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.6 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
0.8 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
0.5 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.2 |
0.5 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.2 |
0.8 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
0.4 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 |
0.4 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
1.0 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.6 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.4 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.1 |
0.6 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.1 |
2.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.9 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.1 |
1.0 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
2.3 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
1.0 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
2.8 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
2.1 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.6 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.1 |
1.6 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
0.6 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.8 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 |
0.4 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.3 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.1 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.1 |
0.4 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
1.1 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.1 |
2.6 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 |
0.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.8 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.8 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.4 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
2.0 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.1 |
0.4 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.6 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.1 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.8 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.1 |
0.4 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.1 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.1 |
0.5 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.4 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.4 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
1.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.8 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.7 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.1 |
0.2 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.1 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.5 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.1 |
0.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.1 |
0.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.6 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
1.4 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.1 |
0.5 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.1 |
0.9 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 |
1.0 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.3 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
2.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.6 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.1 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.1 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 |
1.1 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
1.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.4 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
0.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.1 |
0.2 |
GO:0031946 |
regulation of glucocorticoid biosynthetic process(GO:0031946) |
| 0.1 |
0.3 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
1.0 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.8 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.1 |
2.3 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.4 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
1.7 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.6 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.4 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
1.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.5 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
0.6 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
1.6 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.1 |
1.1 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.1 |
0.9 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.7 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.5 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.5 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 |
0.3 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.1 |
0.6 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 |
0.7 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.1 |
1.2 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.1 |
0.3 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.5 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.3 |
GO:0048007 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 |
0.4 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.5 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
1.8 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.8 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.5 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
1.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.8 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.5 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.3 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.4 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.1 |
0.5 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.8 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.3 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.4 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.4 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 0.1 |
0.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.6 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.3 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.5 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.3 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.8 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
1.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
0.4 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
1.0 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.3 |
GO:2000189 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.8 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.3 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
1.5 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.5 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.2 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.1 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
1.5 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.6 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.9 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.5 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
0.8 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 |
1.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
0.2 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 |
1.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.3 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.5 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.2 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.1 |
0.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.8 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.7 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
0.1 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 |
0.6 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.1 |
0.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
0.4 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.8 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.2 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 |
0.2 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 |
0.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.8 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.2 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.1 |
0.3 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.1 |
0.1 |
GO:0032701 |
negative regulation of interleukin-18 production(GO:0032701) |
| 0.1 |
0.1 |
GO:0033088 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
0.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.9 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.3 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.7 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
2.1 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
0.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
1.0 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.5 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.1 |
0.2 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 |
0.6 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.1 |
0.2 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.1 |
0.9 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.1 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 |
0.3 |
GO:1903347 |
cellular response to testosterone stimulus(GO:0071394) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
0.9 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 |
0.2 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
1.9 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.3 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
1.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.3 |
GO:0071697 |
ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
| 0.1 |
1.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.1 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.1 |
0.2 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.1 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.4 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.2 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 0.1 |
0.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 |
0.1 |
GO:1903391 |
regulation of adherens junction organization(GO:1903391) |
| 0.1 |
0.2 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.1 |
0.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
2.8 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
4.2 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.3 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.5 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
1.6 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.2 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.1 |
GO:0090178 |
establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
1.6 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.1 |
1.7 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
0.4 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.1 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.5 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.3 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.2 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.2 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.2 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 |
0.1 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 |
0.6 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.6 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.3 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
0.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.2 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.7 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.9 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.0 |
1.5 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.7 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 |
1.1 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.3 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.1 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.0 |
0.2 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.0 |
0.1 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 |
0.2 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
0.2 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.0 |
0.0 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.2 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
1.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
1.7 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.0 |
0.6 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.4 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.9 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.3 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.1 |
GO:0046479 |
glycolipid catabolic process(GO:0019377) glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
| 0.0 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.4 |
GO:1900006 |
positive regulation of dendrite development(GO:1900006) |
| 0.0 |
0.2 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.2 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.0 |
0.3 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.2 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
1.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.3 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.1 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.0 |
1.1 |
GO:0048041 |
cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.0 |
0.4 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.1 |
GO:0033128 |
leptotene(GO:0000237) regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) chiasma assembly(GO:0051026) |
| 0.0 |
0.1 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.0 |
0.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.0 |
0.0 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 |
0.2 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.5 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.6 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
7.4 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.0 |
0.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.0 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.5 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.1 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.0 |
0.3 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.4 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.0 |
0.1 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.0 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.0 |
0.6 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.0 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.0 |
0.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.7 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.4 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.3 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.0 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.2 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.0 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.0 |
0.2 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.2 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
1.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.3 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
1.6 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.5 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.8 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
0.0 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.0 |
0.1 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.0 |
0.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 0.0 |
0.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.1 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.6 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.2 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.0 |
0.1 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
1.5 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.1 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.0 |
0.2 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.0 |
0.7 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.0 |
0.2 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.3 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.3 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.5 |
GO:0021871 |
forebrain regionalization(GO:0021871) |
| 0.0 |
0.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 |
0.4 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.9 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.0 |
0.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.7 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.5 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.2 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.4 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.3 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.0 |
0.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
1.1 |
GO:0048814 |
regulation of dendrite morphogenesis(GO:0048814) |
| 0.0 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.1 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.0 |
0.1 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.2 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
1.8 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.1 |
GO:0046886 |
positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
0.1 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.1 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.0 |
0.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.1 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 |
0.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.0 |
0.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.0 |
0.3 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.0 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.0 |
0.5 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.2 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.4 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.2 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.1 |
GO:0072319 |
clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
| 0.0 |
0.1 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.0 |
0.2 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.1 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.0 |
0.2 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.0 |
0.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.0 |
0.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.0 |
0.2 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.0 |
0.5 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
2.2 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.2 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.1 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.1 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.0 |
0.7 |
GO:0071772 |
response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.0 |
0.7 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.3 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.0 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.0 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.0 |
0.1 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.2 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.1 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.2 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.0 |
0.1 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.0 |
0.6 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.0 |
0.2 |
GO:0030500 |
regulation of bone mineralization(GO:0030500) |
| 0.0 |
0.2 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0001914 |
regulation of T cell mediated cytotoxicity(GO:0001914) |
| 0.0 |
0.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.0 |
0.2 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.0 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.0 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.0 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.0 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.0 |
0.0 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
0.0 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.0 |
0.0 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 |
0.0 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.1 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.0 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.4 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.0 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
